Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank.
Hypertension appears to be one of the commonest comorbidities in COVID-19 patients, although whether hypertensive individuals have a higher risk of severe COVID-19 compared with non-hypertensives is unclear. It is also unclear whether the absolute level of systolic blood pressure, or the type of ant...
Saved in:
| Main Authors: | Holly Pavey, Spoorthy Kulkarni, Angela Wood, Yoav Ben-Shlomo, Peter Sever, Carmel McEniery, Ian Wilkinson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276781&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
by: Divya Mohan, et al.
Published: (2023-07-01) -
Impact of major depression on cardiovascular outcomes for individuals with hypertension: prospective survival analysis in UK Biobank
by: Daniel J Smith, et al.
Published: (2019-09-01) -
Sleep patterns and risk of new-onset hypertension and cardiovascular disease in prehypertensive adults: The UK Biobank Study
by: Wanqing Yan, et al.
Published: (2025-09-01) -
Reliability and validity of the UK Biobank cognitive tests.
by: Chloe Fawns-Ritchie, et al.
Published: (2020-01-01) -
Joint association of polysocial risk score and lifestyle with incident essential hypertension: a prospective cohort study in the UK biobank
by: Yumei Zhao, et al.
Published: (2025-07-01)